These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34761839)

  • 1. The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency.
    Pavanello C; Turri M; Strazzella A; Tulissi P; Pizzolitto S; De Maglio G; Nappi R; Calabresi L; Boscutti G
    J Intern Med; 2022 Mar; 291(3):364-370. PubMed ID: 34761839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CER-001 ameliorates lipid profile and kidney disease in a mouse model of familial LCAT deficiency.
    Ossoli A; Strazzella A; Rottoli D; Zanchi C; Locatelli M; Zoja C; Simonelli S; Veglia F; Barbaras R; Tupin C; Dasseux JL; Calabresi L
    Metabolism; 2021 Mar; 116():154464. PubMed ID: 33309714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
    Vaisman BL; Neufeld EB; Freeman LA; Gordon SM; Sampson ML; Pryor M; Hillman E; Axley MJ; Karathanasis SK; Remaley AT
    J Pharmacol Exp Ther; 2019 Mar; 368(3):423-434. PubMed ID: 30563940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein subfractions highly associated with renal damage in familial lecithin:cholesterol acyltransferase deficiency.
    Kuroda M; Holleboom AG; Stroes ES; Asada S; Aoyagi Y; Kamata K; Yamashita S; Ishibashi S; Saito Y; Bujo H
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1756-62. PubMed ID: 24876348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein X Causes Renal Disease in LCAT Deficiency.
    Ossoli A; Neufeld EB; Thacker SG; Vaisman B; Pryor M; Freeman LA; Brantner CA; Baranova I; Francone NO; Demosky SJ; Vitali C; Locatelli M; Abbate M; Zoja C; Franceschini G; Calabresi L; Remaley AT
    PLoS One; 2016; 11(2):e0150083. PubMed ID: 26919698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
    Freeman LA; Shamburek RD; Sampson ML; Neufeld EB; Sato M; Karathanasis SK; Remaley AT
    J Lipid Res; 2019 May; 60(5):1050-1057. PubMed ID: 30808683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Familial LCAT Deficiency in Japan.
    Kuroda M; Bujo H; Yokote K; Murano T; Yamaguchi T; Ogura M; Ikewaki K; Koseki M; Takeuchi Y; Nakatsuka A; Hori M; Matsuki K; Miida T; Yokoyama S; Wada J; Harada-Shiba M
    J Atheroscler Thromb; 2021 Jul; 28(7):679-691. PubMed ID: 33867422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: effects of incubation with lecithin: cholesterol acyltransferase in vitro.
    Norum KR; Glomset JA; Nichols AV; Forte T; Albers JJ; King WC; Mitchell CD; Applegate KR; Gong EL; Cabana V
    Scand J Clin Lab Invest Suppl; 1975; 142():31-55. PubMed ID: 169567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.
    Ishibashi R; Takemoto M; Tsurutani Y; Kuroda M; Ogawa M; Wakabayashi H; Uesugi N; Nagata M; Imai N; Hattori A; Sakamoto K; Kitamoto T; Maezawa Y; Narita I; Hiroi S; Furuta A; Miida T; Yokote K
    J Clin Lipidol; 2018; 12(4):888-897.e2. PubMed ID: 29937398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
    Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
    J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LCAT- targeted therapies: Progress, failures and future.
    Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency.
    Gomaraschi M; Turri M; Strazzella A; Lhomme M; Pavanello C; Le Goff W; Kontush A; Calabresi L; Ossoli A
    Antioxidants (Basel); 2023 Jul; 12(8):. PubMed ID: 37627492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM; Sallee B; Asztalos BF; Pritchard PH; Frohlich J; Schaefer EJ
    J Clin Lipidol; 2014; 8(2):223-30. PubMed ID: 24636183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of the High-Density Lipoprotein Mimetic CER-001 for Inherited Lecithin-Cholesterol Acyltransferase Deficiency.
    Faguer S; Colombat M; Chauveau D; Bernadet-Monrozies P; Beq A; Delas A; Soler V; Labadens I; Huart A; Benlian P; Schanstra JP
    Ann Intern Med; 2021 Jul; 174(7):1022-1025. PubMed ID: 33646847
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.
    Zhu X; Herzenberg AM; Eskandarian M; Maguire GF; Scholey JW; Connelly PW; Ng DS
    Am J Pathol; 2004 Oct; 165(4):1269-78. PubMed ID: 15466392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin:cholesterol acyltransferase-induced transformation of HepG2 lipoproteins.
    McCall MR; Nichols AV; Blanche PJ; Shore VG; Forte TM
    J Lipid Res; 1989 Oct; 30(10):1579-89. PubMed ID: 2515238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.